The drivers underpinning the emergence of SARS-CoV-2 and climate change attest to the fact that we are now living in the Anthropocene Epoch, with human activities significantly impacting and altering the global ecosystem. Here, we explore the historical context of zoonoses, the effect of anthropogenic climate change and interrelated drivers on the emergence of, and response to emerging infectious diseases. We call attention to an urgent need for inculcating a One Health research agenda that acknowledges the primary interconnection between animals, humans, pathogens, and their collective milieus to foster long term resilience across all systems within our shared planetary environment.

AB toxins have historically been associated with significant morbidity, mortality through infections such as botulinum, anthrax, cholera, and diphtheria. These AB toxin-mediated diseases remain prevalent in low and middle income countries, with intermittent outbreaks of Shiga toxin-producing Escherichia coli (STEC) or whooping cough by Bordetella pertussis in high-income countries. These reports warrant an investigation to better understand the distinct characteristics of AB toxins derived from different pathogens. As toxigenic pathogens broaden their scope and diversity, it amplifies the complexity of the problems posed by their AB toxins. Here, we discuss the history, structure and characteristics of key AB toxins, and report on historical and ongoing research on these toxins. We also explore research avenues that hold great promise in potentially improving clinical management of toxin-mediated diseases in the future.